Synairgen announces completion of recruitment into its Phase II Home-Based COVID-19 study of inhaled interferon beta

NEXT STORY
Kaleido Biosciences to Present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” Conference
PREV STORY
Tiziana Life Sciences to Participate in a Fireside Chat at B. Riley Virtual Oncology Investor Conference on 21 January 2021 at 3 pm ET/8 pm GMT
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Germain Dermatology Adds Image-Guided Superficial Radiotherapy with the SRT-100 Vision™ for Treating Basal and Squamous Cell Carcinoma in Charleston, SC

author_avatar
NASDAQ Market News

United Rheumatology Member-Adopted Clinical Pathways are Designed for Lower Cost and Higher Patient Satisfaction

author_avatar
NASDAQ Market News

Pivotal Phase III data at ASCO show Roche’s Tecentriq helps certain people with early lung cancer live significantly longer without their disease returning

author_avatar
NASDAQ Market News